Publications by authors named "Yaron Raiter"

Claim this Profile
I
Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study.
Thomas C Blevins, Yaron Raiter, Bin Sun, Charles Donnelly, Roxann Shapiro

BioDrugs· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
26-Week Open-Label Extension Study Evaluating the Safety and Tolerability of Flexible Doses of Oral Ziprasidone in Children and Adolescents with Bipolar I Disorder (Most Recent Episode Manic).
Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu, Claudia Ianos

J Child Adolesc Psychopharmacol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study.
Robert L Findling, Sarah Atkinson, Mary Bachinsky, Yaron Raiter, Paula Abreu

J Child Adolesc Psychopharmacol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar MYL-1601D with US and European insulin aspart in healthy volunteers: A randomized, double-blind, crossover, euglycaemic glucose clamp study.
Ulrike Hövelmann, Yaron Raiter, Anoop Chullikana, Mark Liu, Charles Donnelly

Diabetes Obes Metab· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studies.
Bin Sun, Nilanjan Sengupta, Anita Rao, Charles Donnelly, Vinit Waichale, Yaron Raiter

BMC Endocr Disord· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of MYL-1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study.
Thomas C Blevins, Abhijit Barve, Yaron Raiter, Patrick Aubonnet, Sandeep Athalye

Diabetes Obes Metab· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study.
Thomas C Blevins, Abhijit Barve, Bin Sun, Yaron Raiter, Patrick Aubonnet

Diabetes Obes Metab· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visually evoked cerebral vasomotor response in smoking and nonsmoking young adults, investigated by functional transcranial Doppler.
László Oláh, Yaron Raiter, Claudia Candale, Sándor Molnár, Bernhard Rosengarten

Nicotine Tob Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis